The Coronavirus International Research Team (COV-IRT) is a community of scientists driving research into COVID-19. This interdisciplinary group from over 28 institutions worldwide is coordinating projects focused specifically on SARS-CoV-2, including determining heterogeneity of the viral genome sequence, analyzing host response to COVID-19 disease, characterizing potential co-infections, and identifying potential therapeutic targets for preclinical and clinical development.
COV-IRT connects molecular biologists, viral epidemiologists, computational biologists, statisticians, coronavirologists, microbiologists, aerobiologists, and clinicians who are identifying new potential therapeutic targets in RNA-Seq datasets from COVID-19 patients with laboratory research scientists who can validate the suitability of those therapeutic candidates and further drug development.
Featured speakers include:
Kizzmekia Corbett, PhD. Scientific Lead of the Coronavirus Vaccines & Immunopathogenesis (coVip) Team at NIAID
Peter J. Hotez, MD, PhD. Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine
Michael Joyner, MD. Principal Investigator and Caywood Professor of Anesthesiology at Mayo Clinic